AAAAAA
Results:
1-15
|
Results: 15
Authors:
Bonomi, P
DiNunno, L
Citation: P. Bonomi et L. Dinunno, Treatment of stage IV non-small-cell lung cancer, CUR CLIN ON, 2002, pp. 215-235
Authors:
Ou, D
Bonomi, P
Jao, W
Jadko, S
Harris, JE
Anderson, KM
Citation: D. Ou et al., The mode of cell death in H-358 lung cancer cells cultured with inhibitorsof 5-lipoxygenase or the free radical spin trap, NTBN, CANCER LETT, 166(2), 2001, pp. 223-231
Authors:
Bonomi, P
Citation: P. Bonomi, Novel approaches for the treatment of non-small cell lung cancer, SEMIN ONCOL, 28(4), 2001, pp. 45-49
Authors:
Belani, CP
Einzig, A
Bonomi, P
Dobbs, T
Capozzoli, MJ
Earhart, R
Cohen, LJ
Luketich, JD
Citation: Cp. Belani et al., Multicenter phase II trial of docetaxel and carboplatin in patients with stage IIIB and IV non-small-cell lung cancer, ANN ONCOL, 11(6), 2000, pp. 673-678
Authors:
Bonomi, P
Kim, KM
Fairclough, D
Cella, D
Kugler, J
Rowinsky, E
Jiroutek, M
Johnson, D
Citation: P. Bonomi et al., Comparison of survival and quality of life in advanced non-small-cell lungcancer patients treated with two dose levels of paclitaxel combined with cisplatin versus etoposide with cisplatin: Results of an eastern cooperativeoncology group trial, J CL ONCOL, 18(3), 2000, pp. 623-631
Authors:
Gandara, DR
Vokes, E
Green, M
Bonomi, P
Devore, R
Comis, R
Carbone, D
Karp, D
Belani, C
Citation: Dr. Gandara et al., Activity of docetaxel in platinum-treated non-small-cell lung cancer: Results of a phase II multicenter trial, J CL ONCOL, 18(1), 2000, pp. 131-135
Authors:
Anderson, KM
Alrefai, WA
Anderson, CA
Bonomi, P
Harris, JE
Citation: Km. Anderson et al., Widespread countervailing genomic responses induced by chemotherapy or radiation as a cause of therapeutic failure, MED HYPOTH, 54(6), 2000, pp. 1000-1002
Authors:
Maida, V
Bennardini, F
Bonomi, P
Ganadu, ML
Iametti, S
Mura, GM
Citation: V. Maida et al., Dissociation of human alpha B-crystallin aggregates by thiocyanate is structurally and functionally reversible, J PROTEIN C, 19(4), 2000, pp. 311-318
Authors:
Harrison, J
Ali, A
Bonomi, P
Prinz, R
Citation: J. Harrison et al., The role of positron emission tomography in selecting patients with metastatic cancer for adrenalectomy, AM SURG, 66(5), 2000, pp. 432-436
Authors:
Bonomi, P
Shirazi, W
Citation: P. Bonomi et W. Shirazi, Chemoradiation in locally advanced non-small cell lung cancer, CANC TREAT, 2000, pp. 171-188
Authors:
Rowinsky, EK
Jiroutek, M
Bonomi, P
Johnson, D
Baker, SD
Citation: Ek. Rowinsky et al., Paclitaxel steady-state plasma concentration as a determinant of disease outcome and toxicity in lung cancer patients treated with paclitaxel and cisplatin, CLIN CANC R, 5(4), 1999, pp. 767-774
Authors:
Ou, D
Anderson, KM
Leslie, W
Bonomi, P
Harris, JE
Citation: D. Ou et al., Does maximizing programmed cell death necessarily yield an optimum clinical advantage?, MED HYPOTH, 52(3), 1999, pp. 235-238
Authors:
Anderson, KM
Ells, G
Bonomi, P
Harris, JE
Citation: Km. Anderson et al., Free radical spin traps as adjuncts for the prevention and treatment of disease, MED HYPOTH, 52(1), 1999, pp. 53-57
Authors:
Anderson, KM
Alrefai, WA
Bonomi, P
Dudeja, P
Ou, D
Anderson, C
Harris, JE
Citation: Km. Anderson et al., Altered oncogene, tumor suppressor and cell-cycle gene expression in PANC-1 cells cultured with the pleiotrophic 5-lipoxygenase inhibitor, MK886, assessed with a gene chip, ANTICANC R, 19(5B), 1999, pp. 3873-3887
Authors:
Bonomi, P
Citation: P. Bonomi, Review of paclitaxel/carboplatin in advanced non-small cell lung cancer, SEMIN ONCOL, 26(1), 1999, pp. 55-59
Risultati:
1-15
|